GNLX has 36-month beta value of -1.18. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for GNLX is 30.04M, and currently, short sellers hold a 8.15% ratio of that float. The average trading volume of GNLX on March 26, 2025 was 218.23K shares.
GNLX) stock’s latest price update
The stock of Genelux Corp (NASDAQ: GNLX) has decreased by -12.60 when compared to last closing price of 3.89.Despite this, the company has seen a loss of -8.11% in its stock price over the last five trading days. globenewswire.com reported 2025-03-25 that WESTLAKE VILLAGE, Calif., March 25, 2025 (GLOBE NEWSWIRE) — Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced the pricing of an underwritten offering of 3,000,000 shares of its common stock at an offering price of $3.50 per share. The gross proceeds to Genelux from the offering are expected to be $10.5 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Genelux.
GNLX’s Market Performance
Genelux Corp (GNLX) has seen a -8.11% fall in stock performance for the week, with a -27.66% decline in the past month and a 55.25% surge in the past quarter. The volatility ratio for the week is 9.74%, and the volatility levels for the past 30 days are at 11.19% for GNLX.. The simple moving average for the past 20 days is -11.55% for GNLX’s stock, with a 21.22% simple moving average for the past 200 days.
Analysts’ Opinion of GNLX
Many brokerage firms have already submitted their reports for GNLX stocks, with Guggenheim repeating the rating for GNLX by listing it as a “Buy.” The predicted price for GNLX in the upcoming period, according to Guggenheim is $8 based on the research report published on October 29, 2024 of the previous year 2024.
ROTH MKM, on the other hand, stated in their research note that they expect to see GNLX reach a price target of $10. The rating they have provided for GNLX stocks is “Buy” according to the report published on August 28th, 2024.
H.C. Wainwright gave a rating of “Buy” to GNLX, setting the target price at $35 in the report published on November 27th of the previous year.
GNLX Trading at -14.05% from the 50-Day Moving Average
After a stumble in the market that brought GNLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -47.69% of loss for the given period.
Volatility was left at 11.19%, however, over the last 30 days, the volatility rate increased by 9.74%, as shares sank -23.42% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +31.78% upper at present.
During the last 5 trading sessions, GNLX fell by -8.11%, which changed the moving average for the period of 200-days by +31.27% in comparison to the 20-day moving average, which settled at $3.84. In addition, Genelux Corp saw 44.07% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GNLX starting from Tyree James L, who sale 3,460 shares at the price of $2.46 back on Dec 30 ’24. After this action, Tyree James L now owns 45,791 shares of Genelux Corp, valued at $8,512 using the latest closing price.
JAMES L TYREE, the Director of Genelux Corp, proposed sale 3,460 shares at $2.46 during a trade that took place back on Dec 30 ’24, which means that JAMES L TYREE is holding shares at $8,512 based on the most recent closing price.
Stock Fundamentals for GNLX
Current profitability levels for the company are sitting at:
- -19.67 for the present operating margin
- 0.56 for the gross margin
The net margin for Genelux Corp stands at -18.79. The total capital return value is set at -0.83. Equity return is now at value -96.85, with -74.41 for asset returns.
Based on Genelux Corp (GNLX), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at -11.69. The debt to equity ratio resting at 0.06. The interest coverage ratio of the stock is -4824.83.
Currently, EBITDA for the company is -26.46 million with net debt to EBITDA at 0.15. When we switch over and look at the enterprise to sales, we see a ratio of 77.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.47.
Conclusion
To put it simply, Genelux Corp (GNLX) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
